SCHEMBL24579014

SCHEMBL24579014

CC1=CNC(C)C(NC(=O)c2cnn3cc(-c4cncc([S+](C)[O-])c4)sc23)=C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24577132 0.83 NAMPT (0.38) —
SCHEMBL24577155 0.82 IKBKE (0.34) —
SCHEMBL24577112 0.81 HDAC6 (0.34) —
SCHEMBL24577993 0.78 MAPT (0.31) —
SCHEMBL24577174 0.76 IKBKE (0.38) —
SCHEMBL24578874 0.76 IKBKE (0.40) —
SCHEMBL24578879 0.75 PDE3B (0.33) —
SCHEMBL24577143 0.74 KMT2A (0.33) —
SCHEMBL24577200 0.71 HDAC6 (0.33) —
SCHEMBL24577786 0.71 IKBKE (0.34) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022136509-A1 PYRAZOLOTHIAZOLE CARBOXAMIDES AND THEIR USES AS PDGFR INHIBITORS ACTELION PHARMACEUTICALS LTD (CH) 2022-06-30 — — WO disclosed
Send feedback